Speed up the progress of drug registration and approval and promote the development of the pharmaceutical industry

" At present, the drug registration review still has the problem of slow progress, low efficiency and over-time limit, which seriously restricts the enthusiasm of research and development investment and innovation of scientific research and development units and enterprises, and affects the innovation and development of Chinese medicine"This year' two sessions of the National Congress, Wang Yuzhi representatives pay close attention to thepharmaceutical industry, she suggested to speed up the review and approval of drugs, to promote the healthy development of the national pharmaceutical industryWang Yuzhi said that in 2007, the relevant departments of the State organized the drug supervision system to declare too many, excessive drug registration applications strictly examined, nearly 10,000 non-compliant drug applications were revokedThe final inspection of only 2200 varieties, and called it a "transitional variety", of which 200 "transitional varieties" have been strictly reviewed, fully comply with the requirements and agreed to approve the production, and in 2008 in the relevant website published" the state has agreed to approve the production and publicity of these varieties, but has not yet issued a drug codeThe production plant of these drugs has been built, equipment has been purchased, raw materials have been bought, because there is no drug code can not be produced, affecting the survival and developmentIn this regard, Wang Yuzhi suggested that to speed up the approval process of drug registration review, for the State Food and Drug Administration has been published on the website of the "transitional varieties" "consent to approve production", should be issued immediately approval number